GATA2 and acute myeloid leukemia: For example, 5% of all AML cases harbor an inv(3)(q21q26.2) or a t(3;3)(q21;q26.2), which repositions the GATA2 enhancer in close vicinity of MECOM, leading to aberrant MECOM expression and GATA2 haploinsufficiency (16).